Abstract
The design and execution of clinical trials poses special problems for cluster headache. Although there is less inter-individual and intra-individual variability of attacks than seen with migraine, the brevity of attacks, spontaneous remissions unrelated to treatment, and the relative rarity of cluster headaches challenge investigators. The International Headache Society has developed guidelines that represent a compromise between scientific rigor and practicality. Only injectable sumatriptan for acute attacks and verapamil for prophylaxis have demonstrated a robust therapeutic effect in controlled clinical trials.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Leone M, D’Amico D, Frediani F, et al.: Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology 2000, 54:1382–1385. Excellent study that clearly demonstrates the superiority of verapamil over placebo.
Manzoni GC, Bono G, Lanfranchi M, et al.: Lithium carbonate in cluster headache: assessment of its short and long-term therapeutic efficacy. Cephalalgia 1983, 3:109–114.
Ekbom K: Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache 1981, 21:132–139.
Wheeler S, Carrazana EJ: Topiramate-treated cluster headache. Neurology 1999, 53:234–236.
Emanual L: Ethics and pain management: an introductory overview. Pain Med 2001, 2:112–116.
Moore RA, Gavaghan D, Tramér MR, et al.: Size is everything-large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998, 78 78:209–216.
Manzoni GC, Terzano MG, Bono G, et al.: Cluster headache-clinical findings in 180 patients. Cephalalgia 1983, 3:21–30.
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society [no authors listed]. Cephalalgia 1988, 8 (suppl 7):1–96.
Lipton RB, Micieli G, Russell D, et al.: Guidelines for controlled trials in cluster headache. Cephalalgia 1995, 15:452–461. Thoughtful review of the challenges facing investigators trying to design clinical trials for cluster headache. Recommended guidelines are a reasonable compromise between highest scientific rigor and practical limitations (eg, brevity of attacks, spontaneous remissions, rarity of cluster headache).
Treatment of acute cluster headache with sumatriptan. The Sumatriptan Cluster Headache Study Group [no authors listed]. N Engl J Med 1991, 325:322–326. This study was well designed and well executed. Injectable sumatriptan was dramatically effective for most patients.
Bahra A, Gawel MJ, Hardebo JE, et al.: Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 2000, 54:1832–1839.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moore, K. Cluster headache: The challenge of clinical trials. Current Science Inc 6, 52–56 (2002). https://doi.org/10.1007/s11916-002-0024-7
Issue Date:
DOI: https://doi.org/10.1007/s11916-002-0024-7